Pitch for Investment

New Antibiotic Compound Enters Phase 1 Clinical Trial

Published: 8th November 2011

UKI2S > News > New Antibiotic Compound Enters Phase 1 Clinical Trial
Clinical Trials

Novacta Biosystems has commenced dosing of the first healthy volunteers in a phase 1 clinical trial of a new antibiotic to treat the hospital superbug Clostridium difficile.

Read the full article

UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.